Literature DB >> 19949688

Symptomatic hypocalcemia in primary hyperaldosteronism: a case report.

Sachin G Pai1, K N Shivashankara, V Pandit, S Sheshadri.   

Abstract

The metabolic alterations caused by hyperaldosteronism are being increasingly recognized and have generated considerable interest among the medical fraternity. Hyperaldosteronism is suspected to have a pivotal role in the patho-physiology of congestive cardiac failure where it has been studied extensively. But its effects on calcium metabolism, parathyroid metabolism and renal handling of calcium are less well described. Recent experimental models have shed light into the roles played by previously unknown mechanisms in causing these metabolic alterations. We hereby report a case of primary hyperaldosteronism due to adrenal adenoma (Conn's syndrome) who presented with a myriad of clinical features including symptomatic hypocalcemia, significant weight loss along with uncontrolled hypertension for a prolonged period before eventually detected to have primary hyperaldosteronism. Surgical removal of the causative tumor resulted in prompt disappearance of all the symptoms and signs and regain of lost weight.

Entities:  

Keywords:  Hypocalcemia; Primary Aldosteronism; Weight Loss

Mesh:

Year:  2009        PMID: 19949688      PMCID: PMC2775880          DOI: 10.3346/jkms.2009.24.6.1220

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  11 in total

Review 1.  Aldosterone in congestive heart failure.

Authors:  K T Weber
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

3.  Calcium paradox of aldosteronism and the role of the parathyroid glands.

Authors:  Alex Vidal; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01       Impact factor: 4.733

4.  Hyperparathyroidism and the calcium paradox of aldosteronism.

Authors:  Vikram S Chhokar; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Linda K Myers; Zhiqing Xing; Richard A Smith; Ivan C Gerling; Karl T Weber
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

5.  Renal calculi in primary hyperaldosteronism.

Authors:  U M Kabadi
Journal:  J Postgrad Med       Date:  1995 Jan-Mar       Impact factor: 1.476

6.  Renal handling of calcium and phosphate during mineralocorticoid "escape" in man.

Authors:  A Rastegar; Z Agus; T B Connor; M Goldberg
Journal:  Kidney Int       Date:  1972-11       Impact factor: 10.612

7.  Loss of bone minerals and strength in rats with aldosteronism.

Authors:  Vikram S Chhokar; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Linda K Myers; Zhiqing Xing; Richard A Smith; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11       Impact factor: 4.733

8.  Primary aldosteronism caused by an adrenal tumor: a correctable cause of hypertension.

Authors:  R J Smith; W L Faulkner
Journal:  J Natl Med Assoc       Date:  1993-10       Impact factor: 1.798

9.  Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.

Authors:  E Rossi; C Sani; F Perazzoli; M C Casoli; A Negro; C Dotti
Journal:  Am J Hypertens       Date:  1995-09       Impact factor: 2.689

10.  [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone].

Authors:  F Jakob; J Seufert; D Haack; K Schröder; J Ludwig; J Rendl; P Vecsei
Journal:  Dtsch Med Wochenschr       Date:  1993-12-17       Impact factor: 0.628

View more
  1 in total

1.  The Management of Primary Hyperaldosteronism in a Poor Technology Environment.

Authors:  Jean Sossa; Dedjinnin Josue Georges Avakoudjo; Dodji Magloire Ines Yevi; Lionelle Fanou; Gilles Natchagande; Michel Michael Agounkpe; Fred Hodonou; Yao Felicien Hounto; Felix Atadokpede
Journal:  Case Rep Urol       Date:  2021-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.